| Literature DB >> 30092106 |
A M Oberbauer1, R Daniels2, K Levy2, T R Famula1, P Mundell2, R Kelley3.
Abstract
Unsaturated omega-3 fatty acids, especially docosahexaenoic acid (DHA), when fed to dogs improves cognitive and neurological development. Supplementation with omega-3 fatty acids such as DHA and eicosapentaenoic acid (EPA) has also been associated with lipid peroxidation, which in turn has been implicated in reduced body weight and altered bone formation. To assess the impact of omega-3 fatty acid supplementation on skeletal growth, diets containing three levels of DHA and EPA (0.01 and 0.01%, 0.14 and 0.12%, and 0.21 and 0.18%, respectively) were fed to bitches during gestation and lactation with puppies also supplemented through weaning. Thus, the subjects studied were the puppies supplemented with DHA and EPA through gestation and early postnatal life. The hip joint conformation of the puppies (n = 676) was recorded at adulthood using two radiographic, non-invasive evaluations. In this population, females had higher hip distraction indices (DI) than males. Males from the lower two levels of DHA and EPA supplementation had significantly smaller hip DI than all females and males from the highest DHA and EPA supplementation. In contrast, there were no diet effects on anatomical indicators of hip joint conformation and no visible arthritic changes. These data suggest that dietary supplementation of DHA and EPA during gestation and the perinatal period to weaning does not adversely influence hip joint formation of dogs.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30092106 PMCID: PMC6084972 DOI: 10.1371/journal.pone.0202157
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Average analytical composition of the supplemental diets (see text for analytical details).
| Diet | ||||
|---|---|---|---|---|
| Nutrient | Units | Low | Moderate | High |
| % | 7.97 | 8.10 | 7.95 | |
| % | 6.50 | 6.53 | 6.61 | |
| Calcium | % | 1.27 | 1.2 | 1.3 |
| Copper | ppm | 20.51 | 19.83 | 20.18 |
| Iron | ppm | 330.49 | 328.36 | 357.93 |
| Potassium | % | 0.65 | 0.65 | 0.69 |
| Magnesium | ppm | 867.31 | 846.35 | 914.43 |
| Manganese | ppm | 48.28 | 48.7 | 48.79 |
| Sodium | ppm | 4405 | 4404 | 4626 |
| Phosphorus | % | 1.02 | 0.98 | 1.06 |
| Zinc | ppm | 238.13 | 226.25 | 238.91 |
| % | 31.32 | 31.73 | 31.39 | |
| Cystine | % | 0.713 | 0.667 | 0.671 |
| Arginine | % | 2.209 | 2.494 | 2.195 |
| Taurine | % | 0.118 | 0.15 | 0.133 |
| Hydroxyproline | % | 0.623 | 0.951 | 0.744 |
| Serine | % | 1.208 | 1.476 | 1.46 |
| Aspartic Acid | % | 2.379 | 2.806 | 2.694 |
| Glutamic Acid | % | 3.955 | 4.596 | 4.453 |
| Threonine | % | 1.17 | 1.378 | 1.337 |
| Glycine | % | 1.976 | 2.656 | 2.341 |
| Alanine | % | 1.751 | 2.121 | 2.007 |
| Proline | % | 1.541 | 1.918 | 1.77 |
| Methionine | % | 0.725 | 0.852 | 0.833 |
| Valine | % | 1.3 | 1.313 | 1.272 |
| Phenylalanine | % | 1.131 | 1.327 | 1.29 |
| Isoleucine | % | 1.176 | 1.226 | 1.171 |
| Leucine | % | 2.122 | 2.435 | 2.418 |
| Histidine | % | 0.409 | 0.593 | 0.883 |
| Lysine | % | 1.766 | 2.06 | 1.968 |
| Tyrosine | % | 0.762 | 0.947 | 0.889 |
| Tryptophan | % | 0.258 | 0.255 | 0.297 |
| % | 21.51 | 20.90 | 21.01 | |
| Palmitic | % | 4.93 | 4.73 | 4.76 |
| Oleic | % | 7.97 | 7.36 | 7.23 |
| Linoleic | % | 4.23 | 3.98 | 3.95 |
| Alpha-linolenic | % | 0.61 | 0.32 | 0.19 |
| Eicosapentaenoic | % | 0.01 | 0.12 | 0.18 |
| Docosahexaenoic | % | 0.01 | 0.14 | 0.21 |
| % | 0.65 | 0.67 | 0.72 | |
| % | 4.56 | 4.31 | 4.29 | |
| 7.02:1 | 6.43:1 | 5.96:1 | ||
| Biotin | mg/kg | 0.75 | 0.73 | 0.58 |
| Niacin | mg/kg | 71.9 | 74.1 | 69.1 |
| Pantothenic Acid | mg/kg | 44.2 | 50.8 | 44.9 |
| Thiamine | mg/kg | 26.2 | 24.4 | 26.0 |
| Vitamin B12 | mg/kg | 0.242 | 0.222 | 0.244 |
| Riboflavin | mg/kg | 22.9 | 17.0 | 17.6 |
| Vitamin B6 | mg/kg | 12.9 | 11.8 | 12.5 |
| Vitamin A | IU/kg | 22006 | 20964 | 21537 |
| Vitamin C | mg/kg | 153 | 167 | 120 |
| Vitamin D | IU/kg | 1720 | 1620 | 2330 |
| Vitamin E | IU/kg | 365 | 370 | 440 |
† Low, moderate, and high refers to the docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) levels in the diet
Breed and sex distribution of dogs by diet with hip joint conformation evaluated.
| Golden retriever | Labrador retriever | Labrador-Golden cross | ||||
|---|---|---|---|---|---|---|
| High | 32 | 36 | 34 | 23 | 61 | 49 |
| Moderate | 17 | 19 | 29 | 29 | 58 | 48 |
| Low | 16 | 18 | 41 | 42 | 62 | 60 |
†One Labrador (low diet) and one Labrador-Golden cross (moderate diet) did not have a recorded sex in the dataset
Fig 1Percentage of hip evaluations as a function of diet for OFA and PennHip assessment schemes.
Data expressed as a percentage of the total number of pups fed either the high (white bar), moderate (gray bar), or low (black bar) DHA and EPA diet. A) OFA hip categories with 1, 2, and 3 were considered non-dysplastic. B) PennHip Distraction Index (DI) measurements with indices presented as whole values; that is, for DI indices ranging from 0.2 to 0.299 they are presented as 0.2 in this figure.
Estimates for hip joints of the OFA scheme and the PennHip scheme as a function of diet and sex.
PennHip measures distraction index on each hip individually, thus data are presented for each hip and the average for a dog. Data are presented as the parameter estimate, standard error (SE) of the estimate, and the low and high highest posterior density (HPD) of the estimate; * indicates the estimates for a given measurement differed by diet (p < 0.05).
| OFA | Average PennHip | Left PennHip | Right PennHip | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diet | |||||||||||||||||
| Estimate | SE | Low HPD | High HPD | Estimate | SE | Low HPD | High HPD | Estimate | SE | Low HPD | High HPD | Estimate | SE | Low HPD | High HPD | ||
| Males | 2.23 | 0.145 | 1.864 | 2.431 | 0.424 | 0.016 | 0.380 | 0.442 | 0.426 | 0.017 | 0.382 | 0.449 | 0.423 | 0.018 | 0.373 | 0.443 | |
| Females | 2.21 | 0.146 | 1.816 | 2.388 | 0.440 | 0.016 | 0.413 | 0.475 | 0.448 | 0.016 | 0.428 | 0.492 | 0.431 | 0.017 | 0.391 | 0.459 | |
| Males | 2.10 | 0.144 | 1.604 | 2.167 | 0.387* | 0.016 | 0.307 | 0.369 | 0.391* | 0.017 | 0.313 | 0.378 | 0.383* | 0.017 | 0.294 | 0.360 | |
| Females | 2.31 | 0.139 | 2.035 | 2.581 | 0.436 | 0.017 | 0.404 | 0.472 | 0.435 | 0.016 | 0.402 | 0.466 | 0.438 | 0.018 | 0.405 | 0.474 | |
| Males | 2.12 | 0.143 | 1.637 | 2.197 | 0.392* | 0.017 | 0.314 | 0.381 | 0.396* | 0.018 | 0.324 | 0.393 | 0.390* | 0.019 | 0.305 | 0.378 | |
| Females | 2.19 | 0.146 | 1.771 | 2.342 | 0.432 | 0.016 | 0.397 | 0.460 | 0.435 | 0.017 | 0.402 | 0.467 | 0.433 | 0.018 | 0.395 | 0.464 | |
Fig 2Relationship of left and right hip distraction indices (DI) with the OFA scores (A) and the relationship of the maximum DI for a given dog with its OFA rating (B). For A, OFA scores of 1 (green dots), 2 (teal dots), and 3 (blue dots) are considered non-dysplastic whereas 4 (peach dots) and 6 (red dots) are considered dysplastic.